Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 4/1998

01-10-1998 | Risk-Benefit Assessment

A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

Authors: Dr Susan M. Hawkridge, Dan J. Stein

Published in: Drug Safety | Issue 4/1998

Login to get access
Metadata
Title
A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents
Authors
Dr Susan M. Hawkridge
Dan J. Stein
Publication date
01-10-1998
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 4/1998
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199819040-00004

Other articles of this Issue 4/1998

Drug Safety 4/1998 Go to the issue

Pharmacoepidemiology

Psychotropic Drug-Induced Sexual Function Disorders

Pharmacoepidemiology

Adverse Effects of Contrast Media

Drug Safety Concepts

Treating Gastro-Oesophageal Reflux Disease During Pregnancy and Lactation

Leading Aticle

Drug Therapy and the Older Person

Drug Experience

Adverse Effects of Regional Anaesthesia in Children

Risk-Benefit Assessment

A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer